1. Home
  2. NXL vs WVVI Comparison

NXL vs WVVI Comparison

Compare NXL & WVVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXL
  • WVVI
  • Stock Information
  • Founded
  • NXL 2010
  • WVVI 1983
  • Country
  • NXL United States
  • WVVI United States
  • Employees
  • NXL N/A
  • WVVI N/A
  • Industry
  • NXL Medical Specialities
  • WVVI Beverages (Production/Distribution)
  • Sector
  • NXL Health Care
  • WVVI Consumer Staples
  • Exchange
  • NXL Nasdaq
  • WVVI Nasdaq
  • Market Cap
  • NXL 24.2M
  • WVVI 31.0M
  • IPO Year
  • NXL 2022
  • WVVI N/A
  • Fundamental
  • Price
  • NXL $1.23
  • WVVI $5.80
  • Analyst Decision
  • NXL Strong Buy
  • WVVI
  • Analyst Count
  • NXL 1
  • WVVI 0
  • Target Price
  • NXL $5.00
  • WVVI N/A
  • AVG Volume (30 Days)
  • NXL 121.2K
  • WVVI 4.7K
  • Earning Date
  • NXL 05-20-2025
  • WVVI 05-20-2025
  • Dividend Yield
  • NXL N/A
  • WVVI N/A
  • EPS Growth
  • NXL N/A
  • WVVI N/A
  • EPS
  • NXL N/A
  • WVVI N/A
  • Revenue
  • NXL $168,721.00
  • WVVI $39,782,442.00
  • Revenue This Year
  • NXL $79.59
  • WVVI N/A
  • Revenue Next Year
  • NXL $334.65
  • WVVI N/A
  • P/E Ratio
  • NXL N/A
  • WVVI N/A
  • Revenue Growth
  • NXL 52.35
  • WVVI 1.65
  • 52 Week Low
  • NXL $0.53
  • WVVI $3.17
  • 52 Week High
  • NXL $4.49
  • WVVI $6.33
  • Technical
  • Relative Strength Index (RSI)
  • NXL 22.27
  • WVVI 44.48
  • Support Level
  • NXL $1.75
  • WVVI $5.42
  • Resistance Level
  • NXL $1.39
  • WVVI $6.07
  • Average True Range (ATR)
  • NXL 0.13
  • WVVI 0.12
  • MACD
  • NXL -0.05
  • WVVI -0.03
  • Stochastic Oscillator
  • NXL 0.01
  • WVVI 57.33

About NXL Nexalin Technology Inc.

Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

About WVVI Willamette Valley Vineyards Inc.

Willamette Valley Vineyards Inc produces and sells premium, super-premium, and ultra-premium wines. The grapes are harvested, fermented, and made into wine at the company's Turner winery, and the wines are sold principally under its Willamette Valley Vineyards label and also under the Griffin Creek, Tualatin Estate, Pambrun, Maison Bleue, Natoma, Metis, and Elton labels. It operates under two operating segments, direct sales and distributor sales. Direct sales include retail sales in its tasting room and remote sites, wine club sales, online sales, on-site events, kitchen and catering sales, and other sales made directly to the consumer without the use of an intermediary. Distributor sales include all sales through a third party where prices are given at a wholesale rate.

Share on Social Networks: